APC Anti-Mouse MHC II (I-A/I-E) Antibody[M5/114]
![APC Anti-Mouse MHC II (I-A/I-E) Antibody[M5/114]](http://files.elabscience.cn/assets/images/loading.png)
Price:
- 应用性： FCM
- 亚型： Rat IgG2b, κ
- 宿主： Rat
| Alternate Names | H2-Ab1/Eb1, I-E beta MHC class II, MHC class II, MHC class II H2-IA-beta-psi, Major histocompatibility protein class II beta chain |
| Cellular Localization |
Membrane
|
| Clone No | |
| Isotype | Rat IgG2b, κ |
| Leadtime |
咨询
|
| Background |
These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.
|
| Abbre | MHC II |
| Swissprot | |
| Host | Rat |
| Reactivity | Mouse |
| Clonality | Monoclonal |
| Isotype Control | |
| Applications | |
| Form | Liquid |
| Concentration | 5 μL/Test |
| Conjugation | APC |
| Conjugation Information | APC is designed to be excited by the Red (627-640 nm) laser and detected using an optical filter centered near 660 nm (e.g., a 660/20 nm bandpass filter). |
| Spectrum | |
| Storage Buffer | Phosphate buffered solution, pH 7.2, containing 0.09% sodium azide and 1% BSA. |
| Storage | This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
| Expiration Date | 12个月 |
| Shipping |
冰袋 |
| Gene ID |
-
Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
IF: 15.800 -
A low-molecular-weight α-glucan from edible fungus Agaricus blazei Murrill activates macrophage TFEB-mediated antibacterial defense to combat implant-associated infection
IF: 10.700 -
Structural characterization and adjuvant activity of a water soluble polysaccharide from Poria cocos
IF: 7.700Journal： INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)Reactivity：MouseSample Type：draining lymph nodes (LNs) tissue -
Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer
IF: 3.500 -
Single-dose of hybrid eukaryotic-prokaryotic nanovesicles to drive a rapid and controllable immune response against Klebsiella pneumoniae induced nosocomial pneumonia
IF: 17.400 -
An Alternative Thinking in Tumor Therapeutics: Living Yeast Armored with Silicate
IF: 17.100 -
The self-adjuvant heterocyclic lipid nanoparticles encapsulated with vaccine and STAT3 siRNA boost cancer immunotherapy through DLN-targeted and STING pathway
IF: 15.100 -
Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8+T cell infiltration
IF: 10.200 -
In Vitro and In Vivo Dendritic Cell Immune Stimulation Effect of Low Molecular Weight Fucoidan from New Zealand Undaria pinnatifida
IF: 5.118
| E-CK-A105 | 10×ACK Lysis Buffer | 500mL , 200mL , 100mL |
| E-CK-A107 | Cell Staining Buffer | 500mL , 200mL , 100mL |
